Potential Benefits of Antioxidant Phytochemicals in Type 2 Diabetes

Arman Arabshomali1, Shadi Bazzazzadehgan1, Fakhri Mahdi2

  • 1Department of Pharmacy Administration, School of Pharmacy, University of Mississippi, University, MS 38677, USA.

PubMed

Insights

This study explores how antioxidants, particularly polyphenols, may combat inflammation and oxidative stress in type 2 diabetes (T2DM). They show promise as an adjuvant therapy for treatment-resistant diabetes and related complications.

Area of Science:

  • Biochemistry
  • Endocrinology
  • Nephrology

Background:

  • The link between diabetes and inflammation is well-established, with oxidative stress and lipid peroxidation implicated in chronic kidney disease in type 2 diabetes mellitus (T2DM).
  • Hyperglycemia, inflammation, and reactive oxygen species are interconnected, contributing to diabetes development and progression.
  • The hyperglycemia-inflammation-oxidative stress axis impacts vascular, kidney, liver, and pancreatic health, presenting a therapeutic target.

Purpose of the Study:

  • To review preclinical, in vivo, and clinical research on antioxidants for preventing or treating inflammation in T2DM.
  • To analyze the efficacy of antioxidants as adjuvant therapy for treatment-resistant diabetes.
  • To propose future research directions for antioxidant-based diabetes clinical trials.

Main Methods:

  • Systematic review of existing literature.
  • Analysis of preclinical, in vivo, and clinical studies.
  • Synthesis of findings on antioxidant and anti-inflammatory effects of polyphenols.

Main Results:

  • Antioxidants, especially polyphenols, demonstrate potential anti-inflammatory and antioxidant activities.
  • These agents may serve as beneficial adjuvant therapies, particularly in cases of treatment-resistant diabetes.
  • Evidence suggests a role for antioxidants in mitigating T2DM-associated complications.

Conclusions:

  • The interaction of hyperglycemia, inflammation, and oxidative stress is a key factor in T2DM complications.
  • Antioxidants, particularly polyphenols, hold therapeutic promise for T2DM management and prevention of associated diseases.
  • Further clinical trials are warranted to fully elucidate the role of antioxidants in T2DM treatment.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.2K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
290
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
212
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
557
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K